Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1039–1052. doi: 10.1016/j.jaip.2016.08.005

Figure 5. Therapeutic approach for ILD in PAD.

Figure 5

Treatment algorithm for management of ILD in PAD patients. AZA, azathioprine; LABA, long-acting β-agonist; MMF, mycophenolate mofetil; RTX, rituximab; 6MP, 6-mercaptopurine.